Peter Barry

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013)

Vito Amoroso, Daniele Generali, Thomas A. Buchholz et al. · JNCI Monographs · 2015 · 96 citations · Full text

Surgical Oncology, Breast Oncology, Cancer Management +20

Effects of Ivacaftor in Patients With Cystic Fibrosis Who Carry the G551D Mutation and Have Severe Lung Disease

Peter Barry, Barry J. Plant, Arjun Nair et al. · CHEST Journal · 2014 · 92 citations

Advanced Lung Disease, Pathology, Pulmonary Fibrosis +4

Reparative epiretinal fibrosis after diabetic vitrectomy.

Peter Barry, P. S. Hiscott, Ian Grierson et al. · PubMed · 1985 · 47 citations

Longitudinal effects of elexacaftor/tezacaftor/ivacaftor on liver tests at a large single adult cystic fibrosis centre

Daniel Tewkesbury, Varinder Athwal, R.J. Bright-Thomas et al. · Journal of Cystic Fibrosis · 2023 · 47 citations · Full text

Hepatology, Liver Tests, Liver Physiology +6

Longitudinal effects of ivacaftor and medicine possession ratio in people with the<i>Gly551Asp</i>mutation: a 5-year study

Ruth M. Mitchell, Andrew Jones, Katie Stocking et al. · Thorax · 2021 · 36 citations